Treatment Gap
Cross-source consensus on Treatment Gap from 1 sources and 5 claims.
1 sources · 5 claims
Risks & contraindications
Comparisons
Evidence quality
Other
Highlighted claims
- The study defined the treatment gap as the share of eligible patients who were not prescribed the relevant therapy at discharge. — Treatment gaps in guideline-directed medical therapy for HFrEF in Singapore: findings from a multicentre retrospective cohort study
- In 2022, only 29% of eligible patients received quadruple therapy at discharge, leaving a 71% treatment gap. — Treatment gaps in guideline-directed medical therapy for HFrEF in Singapore: findings from a multicentre retrospective cohort study
- Most patients were eligible for GDMT, but prescribing was much lower. — Treatment gaps in guideline-directed medical therapy for HFrEF in Singapore: findings from a multicentre retrospective cohort study
- Underuse of quadruple therapy persisted even after excluding patients with relative cautions as well as contraindications. — Treatment gaps in guideline-directed medical therapy for HFrEF in Singapore: findings from a multicentre retrospective cohort study
- About 7% of the cohort was discharged without any foundational GDMT drug. — Treatment gaps in guideline-directed medical therapy for HFrEF in Singapore: findings from a multicentre retrospective cohort study